Sarel Halachmi

Clinical Prof.

    Calculated based on number of publications stored in Pure and citations from Scopus
    1993 …2023

    Research activity per year

    Filter
    Patent

    Search results

    • 2016

      SEMAPHORIN 3A AS A DIAGNOSTIC MARKER FOR UROTHELIAL CANCER

      Vadasz, Z., Halachmi, S., Rubinstein, J., Nativ, O. & Toubi, E., 13 Oct 2016, IPC No. G01N 33/ 574 A I, Patent No. US2016299142, Priority date 2 Dec 2014, Priority No. US201415101112

      Research output: Patent